Tag - takeda

 
Menu
Search
 
July 16, 2025
 

Today's print edition

Home Delivery
Subscribe for more access

TAKEDA

Capsules of Takeda Pharmaceutical's Prevacid heartburn drug. The company's share price dropped by over 5% on Monday after U.S. President Donald Trump announced a plan to order a cut in U.S. prescription drug costs.
BUSINESS / Markets
May 12, 2025
Asian pharma stocks tumble on Trump signal to cut U.S. drug prices
The U.S. president's social media post put pressure on drug-related stocks on worries their profits will take a hit if they have to reduce prices in the U.S.
Takeda Pharmaceutical's headquarters in Tokyo
BUSINESS / Companies
Jan 30, 2025
Takeda picks first female CEO of centuries-old drugmaker
Julie Kim, 54, has been running Takeda’s U.S. operations since 2022 and will assume the role of CEO in June next year, subject to shareholder approval, the company said.
Takeda Pharmaceutical raised its full-year operating profit guidance to ¥265 billion from ¥225 billion, citing a stronger than expected first-half performance and updated currency assumptions.
BUSINESS
Oct 31, 2024
Japan's Takeda raises full-year profit forecast amid restructuring
Takeda raised its full-year operating profit guidance to ¥265 billion from ¥225 billion, citing a stronger than expected first-half performance.
Takeda Pharmaceutical is in talks to make its dengue vaccine available in India.
BUSINESS / Companies
Feb 28, 2024
Takeda in regulatory talks to launch dengue vaccine in India
Takeda's dengue vaccine is currently available for children and adults in countries like Indonesia, Thailand, Argentina and Brazil.
Medics tend to COVID-19 patients at the intensive care unit of a hospital in Sofia, Bulgaria, in 2022.
JAPAN / Science & Health
Oct 7, 2023
Japan-led team identifies how severe COVID-19 cases develop
The research results are expected to facilitate the development of drugs to prevent serious COVID-19 complications.
Japan Times
BUSINESS
Mar 4, 2023
Japanese pharmaceutical firm Takeda lowers price of dengue shot in Brazil and Indonesia
The cost for Qdenga in Indonesia will be about one-third its European price, far lower than many other innovative vaccines, Takeda CEO Christophe Weber said in an interview.
Japan Times
BUSINESS / Companies
Dec 14, 2022
Takeda to pay up to $6 billion for Nimbus immune-therapy drug
After an initial $4 billion payment upfront, U.S.-based Nimbus is eligible for two additional $1 billion payments based on sales.
Japan Times
JAPAN
Sep 2, 2021
Moderna to recall COVID-19 doses in Japan over stainless steel contaminants
The health ministry said particles of stainless steel were found in suspended Moderna COVID-19 vaccines, but it did not expect they would pose an additional health risk.
Japan Times
JAPAN / Science & Health
May 23, 2021
Japan clinical trial of COVID-19 plasma therapy highlights slow-moving medical policy
Doctors are gearing up for clinical trials of convalescent plasma therapy, but many overseas hospitals have already moved on to other remedies.
Japan Times
JAPAN
Mar 5, 2021
Japan's Takeda seeks government approval for Moderna COVID-19 vaccine
While awaiting regulatory approval, Takeda plans to start distributing the Moderna vaccine in the first half of this year.
Japan Times
BUSINESS / Companies
Aug 24, 2020
Takeda to sell consumer unit to Blackstone for ¥242 billion
Takeda Pharmaceutical Co. agreed to sell its Japanese consumer health care business for ¥242 billion ($2.3 billion) to Blackstone Group Inc., which plans to take the over-the-counter medication unit public in about five years.
Japan Times
BUSINESS / Companies
Jul 31, 2020
Taisho emerges as lead bidder for Takeda $3 billion consumer unit
Taisho Pharmaceutical Holdings Co. has emerged as the leading contender to acquire Takeda Pharmaceutical Co.’s Japanese consumer health care business, according to people familiar with the matter.
Japan Times
BUSINESS
Mar 4, 2020
Japan's largest drugmaker working to develop virus treatment, Dow Jones reports
Takeda Pharmaceutical Co. is developing an experimental therapy for the novel coronavirus with the goal of making it available in 9 to 18 months, the nation's largest drugmaker said.
Japan Times
BUSINESS / Companies
Feb 20, 2020
As COVID-19 spreads, Takeda CEO urges more industry investment in vaccines
The spread of novel coronavirus infections is starting to make one thing clear: More vaccine investment is needed, the CEO of Asia's biggest drugmaker said.
Japan Times
JAPAN / Science & Health
Nov 7, 2019
Takeda's dengue vaccine said effective overall in study but with major limitation
Takeda Pharmaceutical Co.'s experimental dengue vaccine was highly effective at preventing the mosquito-borne disease in a late stage study, but it failed to protect against one type of the virus in people with no prior exposure to dengue.
Japan Times
BUSINESS / Companies
Oct 11, 2019
Takeda nears deal on sale of Russia, Mideast and Africa assets to private equity firms
Takeda Pharmaceutical Co. is nearing the sale of a portfolio of assets in the Middle East, Africa and Russia to separate buyout firms that could help the drugmaker raise about $1 billion to reduce debt, according to people familiar with the matter.
Japan Times
BUSINESS / Companies
Sep 27, 2019
Takeda Pharmaceutical to sell drug assets in emerging markets and Europe, sources say
Takeda Pharmaceutical Co. is close to selling some assets in emerging markets and Western Europe, people familiar with the matter said, in a move that would help the Japanese drugmaker reduce its debt pile.
Japan Times
JAPAN / Science & Health
Jun 11, 2019
As its drug firms consider move to Tokyo, does Osaka have a future as a modern city of medicine?
The Doshomachi area of the city of Osaka has been the home and birthplace of many pharmaceutical companies since the Edo Period (1603-1868), including some of the leading drugmakers such as Ono Pharmaceutical Co.
Japan Times
BUSINESS / Companies / FOCUS
Feb 3, 2019
Bypassing U.S. regulators, Takeda takes its dengue shot to the tropics first
A new vaccine for the dengue virus is taking a potentially risky road to prevent the mosquito-borne disease that infects nearly 400 million people each year.
Japan Times
BUSINESS
Jan 30, 2019
Takeda dengue vaccine meets main goal of trial; detailed results to come
Takeda Pharmaceutical Co. said Tuesday that its experimental dengue vaccine appears to be safe and effective at preventing all four types of the mosquito-borne disease, meeting the main goal of the drugmaker's late-stage clinical trial.
Students in Japan struggle with Japanese language and math sections on national exam
The correct answer rate for the Japanese language section on a national test dropped to 67.0% from 67.8% the previous year among elementary school sixth-graders.
Japan team finds ancient ocean full of squids
The ancient ocean was full of squids, whose population exceeded that of fish or ammonites, a Japanese research team mainly from Hokkaido University has found through a new method using technology.
Japan researchers identify gut bacteria strain that boosts anticancer drugs
Researchers at the National Cancer Center Japan say a new type of gut bacteria named YB328 could help unlock the potential of cancer immunotherapy.
Tourists in Japan have telemedicine options before calling 119
Foreign tourists at Tsukiji Outer Market in Tokyo. More than 1 million international visitors have a medical issue in Japan every year.
How remote work is rewriting the migrant experience in Japan
After pandemic-era border regulations eased, Indian migrants began returning to Japan. Their population now stands at more than 50,000 across the country.
Japanese scientists discover clue to why women burn more fat than men
Scientists say a recently-published study could help explain why women are typically less prone to weight-related conditions and may lead to new therapies that target calorie-burning mechanisms.
Music idol and anime fandom merch is big business
Businesses who cater to fandoms gathered at Tokyo Lifestyle Week for the second annual Oshikatsu — Merch Collection Expo, a trade show devoted to fandom goods.
U.S. urges clarity on Japan’s role in potential war over Taiwan, report says
A Ground Self-Defense Force member conducts a military drill with an anti-ship missiles unit, at the GSDF's base on Miyako Island in Okinawa Prefecture in April 2022.
Tourists in Japan have telemedicine options before calling 119
Foreign tourists at Tsukiji Outer Market in Tokyo. More than 1 million international visitors have a medical issue in Japan every year.
Is Japanese skin really ‘too smooth’ for Hideo Kojima’s games?
Hideo Kojima, the leading auteur in Japanese video games, has skirted controversy in the wake of the release of Death Stranding 2: On the Beach

Podcast

One of the many entrances to the Kabukicho neighborhood in Tokyo’s Shinjuku Ward.
Kabukicho: Tokyo’s ‘stadium of desire’

Longform

After pandemic-era border regulations eased, Indian migrants began returning to Japan. Their population now stands at more than 50,000 across the country.
How remote work is rewriting the migrant experience in Japan
By Megha Wadhwa

SUSTAINABLE JAPAN

Smile! It’s ‘Sanrio Time,’ now and ever after
Smile! It’s ‘Sanrio Time,’ now and ever after

SPECIAL SUPPLEMENTS note

Read more

SUPPLEMENTS BINDER